Literature DB >> 23247051

Analysis of a Chinese pedigree with Zellweger syndrome reveals a novel PEX1 mutation by next-generation sequencing.

Yan Sun1, Lixia Wang, Xiaoming Wei, Qian Zhu, Yun Yang, Zhangzhang Lan, Ning Qu, Yuxing Chu, Yuhui Wang, Shuang Yang, Yu Liang, Wei Wang, Xin Yi.   

Abstract

BACKGROUND: Autosomal recessive Zellweger spectrum disorder (ZSD), the main subgroup of the peroxisome biogenesis disorders (PBDs), can be caused by mutations in any of the 13 PEX genes. Zellweger syndrome (ZS) is the most common and severe phenotype in the heterogeneous ZSD. For the large number genes involved, it is difficult to make a precise genetic diagnosis by traditional methods at a time. A combination of enrichment of targeted genes and next-generation sequencing (NGS) would result in both high efficiency and low cost for targeted sequencing of genes of interest.
METHODS: To identify potential mutations in a Chinese family associated with Zellweger syndrome, 1930kb of all the targeted region of PEX genes were captured and sequenced using NGS. We also performed Sanger sequencing to validate the NGS results.
RESULTS: Here, we reported a Chinese patient diagnosed as a severe classic type of PBD based on a clinical investigation. We then performed microarray-based NGS to detect the variants in PEX genes of the whole family. One reported heterozygosis mutation (c.782_783delAA) was identified in the patient's father and one novel heterozygosis missense mutation (c.475G>C) was found in the patient's mother, the patient inherited both mutations.
CONCLUSIONS: The results proved that the application of target sequence capture using chip and high-throughput NGS is a valuable tool for the molecular diagnosis of peroxisome biogenesis disorders. The accuracy, high-throughput and speed of the method make it suitable for clinical application.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247051     DOI: 10.1016/j.cca.2012.12.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.

Authors:  Nancy E Braverman; Gerald V Raymond; William B Rizzo; Ann B Moser; Mark E Wilkinson; Edwin M Stone; Steven J Steinberg; Michael F Wangler; Eric T Rush; Joseph G Hacia; Mousumi Bose
Journal:  Mol Genet Metab       Date:  2015-12-23       Impact factor: 4.797

2.  Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.

Authors:  Xiaoling Ma; Jinping Li; Brian Brost; Wenjun Cheng; Shi-Wen Jiang
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

3.  Targeted next-generation sequencing as a comprehensive test for Mendelian diseases: a cohort diagnostic study.

Authors:  Yan Sun; Jianfen Man; Yang Wan; Gao Pan; Lique Du; Long Li; Yun Yang; Liru Qiu; Qing Gao; Handong Dan; Liangwei Mao; Zhengyu Cheng; Chen Fan; Jing Yu; Mufei Lin; Karsten Kristiansen; Yin Shen; Xiaoming Wei
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.